Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1599-1603

  Akram, Muhammad ^a   Malik, F A ^a   Kayani, Mahmood Akhtar ^a  

^a Comsats Institute oflnformation Technology ^*  (Pakistan)

Author keywords

Breast cancer susceptibility gene; MTHFR; Pakistani breast cancer; SSCP

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ARTICLE; ASIAN; BREAST TUMOR; CASE CONTROL STUDY; EXON; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PAKISTAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PAKISTAN; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 84871922220     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1599     Document Type: Article

References (38)

1. Ames BN (1999). Cancer prevention and diet: help from single nucleotide polymorphisms. Proc Natl Acad Sci USA, 96, 12216-8.
2. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5.
3. Feigelson HS, Jonas CR, Robertson AS, et al (2003). Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev, 12, 161-4.
4. Ford ES, Bowman BA (1999). Serum and red blood cells folateconcentrations, race and education: Finding from the third National Health and nutrition survey. Am J Clin Ntr, 134, 1786-92.
5. Frosst P (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
6. Gaughan DJ, Barbaux S, Kluijtmans LA, Whitehead AS (2000). The human and mouse methylenetetrahydrofolate reductase (MTHFR) genes: genomic organization, mRNA structure and linkage to the CLCN6 gene. Gene, 257, 279-89.
7. Gershoni-Baruch R, Dagan E, Israeli D, et al (2000). Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur Cancer, 36, 2313-6.
8. Goyette P, Pai A, Milos R, et al (1999). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome, 9, 652-6.
9. Henríquez-Hernández LA, Pérez LF, Hernández AG, et al (2010). TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy. Cancer Epidemiol, 34, 490-3.
10. Henríquez-Hernández LA, Murias-Rosales A, Hernández González A, et al (2009). Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study. Oncology Reports, 22, 1425-33.
11. Helms C (1990). Salting out Procedure for Human DNA extraction. In The Donis-Keller Lab - Lab Manual Homepage.
12. Justenhoven C, Hamann U, Pierl CB, et al (2005). One-corbon metabolism in breast cancer risk in colon and no association of MTHFR, MTR and TYMS polymorphism in the GENICA study from the Germany. Cancer Epidemiol Biomarkers Prev, 14, 1315-8.
13. Jencks DA, Mathews RG (1987). Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. JBiol Chem, 262, 2485-93.
14. Kotsopoulos J, Zhang WW, Zhang S, et al (2008). Polymorphism in folate metabolizing enzymes and transport proteins and risk of breast cancer. Breast Can Res Treat, 112, 585-93.
15. Kim YI (2000). Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene- nutrient interactions in carcinogenesis. NutrRev, 58, 205-9.
16. Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms, and implications. JNutrBiochem, 10, 66-88.
17. Kang SS, Zhou J, Wong PW (1988). Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. AmJHum Genet, 43, 414-21.
18. Lee SA, Kang D, Nishio H, et al (2004). Methylenetetrahydrofolate reductase polymorphism, diet and breast cancer in Korean women. Exp Mol Med, 36, 116-21.
19. Langsenlehner U, Krippl P, Renner W, et al (2003). The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast CancerRes Treat, 81, 169-72.
20. Mushahida Batool, Mustafa Arian, Javaid Gardezi (2005). An experience with breast disease in a surgical unit of a teaching hospital of Lahore. Biomedica, 21, 16.
21. Marchand L (2004). MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 13, 2071-7.
22. Molloy AM, Daly S, Mills JL, et al (1997). Thermolabile variant of 5, 10-Methylenetetrahydrofolate reductase associated with low red-cell folate: implications for folate intake recommendations. Lancet, 349, 1591-3.
23. Mason JB, Levesque T (1996). Folate effects on carcinogenesis and potential for cancer chemoprevention. Oncology, 10, 1727-36.
24. Matthews RG, Daubner SC (1982). Modulation of methylenetetrahydrofolate reductase activity by S-adenosylmethionine and by dihydrofolate and its polyglutamate analogues. Adv Enzyme Regul, 20, 123-31.
25. Mudd SH, Uhlendorf BW, Freeman JM (1972). Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun, 46, 905-12.
26. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989). Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA, 86, 2766-70.
27. Perry CA, Renna SA, Khitun E, et al (2004). Ethnicity and race influence the folate status response to controlled folate intakes in young women. JNutr, 134, 1786-92.
28. Rady PL (2002). Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet, 107, 162-8.
29. Rohan TE, Jain MG, Howe GR, Miller AB (2000). Dietary folate consumption and breast cancer risk. J Natl Cancer Inst, 92, 266-9.
30. Rozen R (1997). Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost, 78, 523-6.
31. Rosenblatt DS (1995). Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaud et al., Sly WS. The metabolic and molecular bases of inherited disease. New York, NY, McGraw-Hill Book Company, 3111-28.
32. Sharp L (2002). Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). CancerLett, 181, 65-71.
33. Sellers TA, Kushi LH, Cerhan JR, et al (2001). Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology, 12, 420-8.
34. Shrubsole MJ, Jin F, Dai Q, et al (2001). Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. CancerRes, 61, 7136-41.
35. Tran P, Ledere D, Chan M (2002). Multiple transcription start sites and alternative splicing in the methylenetetrahydrofolate reductase gene result in two enzyme isoforms. Mamm Genome, 13, 483-92.
36. Walsh T, Casadei S, Coats KH, et al (2006). Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA, 295,1379-88.
37. Weisberg I (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72
38. Zang S, Hunter DJ, Hankinson SE, et al (1999). A prospective study of folate intake and risk of breast cancer. JAMA, 281, 1632-7.